- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| INIFY LABORATORIES Aktie jetzt für 0€ handeln | |||||
| Mo | INIFY LABORATORIES AB: Inify Laboratories signs agreement with University Hospitals Plymouth NHS Trust to support faster prostate cancer diagnostics | 2 | Cision News | ||
| 27.05. | INIFY LABORATORIES AB: Inify Laboratories announces CQC registration and full operational launch of its state-of-the-art UK histopathology laboratory | 1 | Cision News | ||
| 21.05. | Inify Laboratories AB (publ) - Bulletin from the Annual General Meeting 2026 | 1 | Cision News | ||
| 29.04. | INIFY LABORATORIES AB: Inify Laboratories: Progress in the dialogue with NHS in the UK and continued growth in Sweden | - | Oslo Børs | ||
| 24.04. | INIFY LABORATORIES AB: Inify Laboratories has signed an agreement with Region Jämtland Härjedalen for prostate cancer diagnostics | - | Oslo Børs | ||
| 15.04. | INIFY LABORATORIES AB: Inify Laboratories - Annual Report 2025 | 1 | Cision News | ||
| 15.04. | INIFY LABORATORIES AB: Inify Laboratories - notice of Annual General Meeting on May 20, 2026 | 1 | Cision News | ||
| 24.03. | INIFY Laboratories AB: Inify Laboratories - New share capital registered | 3 | Oslo Børs | ||
| 27.02. | INIFY LABORATORIES AB: Gastrointestinal Service Launch and Progress in the UK Expansion | 3 | Cision News | ||
| 25.02. | INIFY Laboratories AB: Inify Laboratories: Solid topline growth, strong UK development, and positive response to gastrointestinal diagnostics | 3 | Oslo Børs | ||
| 30.01. | INIFY LABORATORIES AB: Correction: Inify Laboratories - mandatory notification of trade | 1 | Cision News | ||
| 27.01. | INIFY Laboratories AB: Inify Laboratories - Final Results of the Repair Issue | - | Oslo Børs | ||
| 27.01. | INIFY Laboratories AB: Inify Laboratories - mandatory notification of trade | - | Oslo Børs | ||
| 12.01. | INIFY LABORATORIES AB: Inify Laboratories - Commencement of subscription period for Repair Issue | 1 | Cision News | ||
| 19.12.25 | INIFY Laboratories AB: Inify Laboratories - mandatory notification of trade | 1 | Oslo Børs | ||
| 19.12.25 | INIFY Laboratories AB: Inify Laboratories announces final results of fully guaranteed private placement | 1 | Oslo Børs | ||
| 17.12.25 | INIFY Laboratories AB: Inify Laboratories: Key information regarding Repair Issue | 1 | Oslo Børs | ||
| 17.12.25 | INIFY LABORATORIES AB: Inify Laboratories announces preliminary results of fully guaranteed private placement | 1 | Cision News | ||
| 16.12.25 | INIFY Laboratories AB: Inify Laboratories - notification of trade | 2 | Oslo Børs | ||
| 16.12.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 16.12.2025 | 796 | Xetra Newsboard | Das Instrument 48Z0 US4432012072 HOWMET AEROSPACE 3,75 PFD EQUITY wird cum Kapitalmassnahme gehandelt am 16.12.2025 und ex Kapitalmassnahme am 17.12.2025 The instrument 48Z0 US4432012072 HOWMET AEROSPACE... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BILLIONTOONE | 99,65 | 0,00 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 27,690 | 0,00 % | PROCEPT BioRobotics shares slide after Leerink downgrade cites rising competitive risks | ||
| ALIGNMENT HEALTHCARE | 20,225 | -0,07 % | Alignment Healthcare (ALHC) Soars 25.1%: Is Further Upside Left in the Stock? | ||
| BRIGHTSPRING HEALTH SERVICES | 63,08 | 0,00 % | Goldman Sachs initiates BrightSpring Health stock at Buy with $71 target | ||
| GENEDX | 60,99 | 0,00 % | Sema4.ai's autonomous agent building platform gets simpler to use, adds deeper business context and more | ||
| PRIVIA HEALTH GROUP | 23,360 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,480 | +2,02 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| LUMEXA IMAGING | 9,520 | 0,00 % | Lumexa Imaging Holdings, Inc.: Lumexa Imaging Announces First Quarter 2026 Results | RALEIGH, N.C., May 12, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (Nasdaq: LMRI), one of the nation's largest providers of outpatient imaging services, today announced results for the first quarter ended... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 8,610 | 0,00 % | Goldman Sachs initiates Lifestance Health stock at neutral | ||
| ADAPTHEALTH | 10,100 | 0,00 % | AdaptHealth Corp. - 10-Q, Quarterly Report | ||
| PROGYNY | 25,640 | -0,04 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| FRESENIUS | 37,980 | +1,96 % | FRESENIUS SE & CO KGAA - Stabilität mit Fokus auf Struktur | ||
| HEARTFLOW | 30,670 | 0,00 % | Piper Sandler bestätigt Rating für Heartflow: Plaque-Umsätze sollen Wachstum antreiben | ||
| BETA BIONICS | 14,690 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 35,100 | +2,03 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen |
INIFY LABORATORIES AB gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,492 Euro und damit +4,24 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INIFY LABORATORIES AB finden Sie auf Wallstreet Online.